Genomic and expression analysis of microdissected inflammatory breast cancer

Breast Cancer Research and Treatment

Volumn 138, Issue 3, 2013, Pages 761-772

  Woodward, Wendy A ^a   Krishnamurthy, Savitri ^a   Yamauchi, Hideko ^b   El Zein, Randa ^a   Ogura, Dai ^c   Kitadai, Eri ^b   Niwa, Shin Ichiro ^c   Cristofanilli, Massimo ^a   Vermeulen, Peter ^e   Dirix, Luc ^e   Viens, Patrice ^d   Van Laere, Steve ^e,f   Bertucci, François ^d   Reuben, James M ^a   Ueno, Naoto T ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

^c Link Genomics Inc   (Japan)

^d INSTITUT PAOLI CALMETTES   (France)

^e SINT AUGUSTINUS HOSPITAL   (Belgium)

^f UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Array; CGH; Gene signature; Inflammatory breast cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; RECEPTOR SUBTYPE;

ABCF1 GENE; ARTICLE; BAT3 GENE; C6ORF47 GENE; C6ORF62 GENE; C6ORF89 GENE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CSNK2B GENE; EHMT2 GENE; GENE; GENE CLUSTER; GENE DOSAGE; GENE EXPRESSION; GENE OVEREXPRESSION; GENOMICS; HUMAN; HUMAN CELL; INFLAMMATORY BREAST CANCER; MDC1 GENE; MICRODISSECTION; MTCH1 GENE; NFKB1L1 GENE; OR2B6 GENE; PREDICTIVE VALUE; PRIORITY JOURNAL; TTRAP GENE; TUBB GENE; VALIDATION STUDY; ZNF184 GENE; ZNF217 GENE;

COHORT STUDIES; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HUMANS; INFLAMMATORY BREAST NEOPLASMS; MICRODISSECTION; PREDICTIVE VALUE OF TESTS; RECEPTOR, ERBB-2; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER;

EID: 84877802557     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2501-6     Document Type: Article

References (14)

1. Bertucci F, Finetti P, Rougemont J, Charafe-Jauffret E, Cervera N, Tarpin C et al (2005) Gene expression profiling identifies molecular subtypes of inflammatory breast cancer. Cancer Res 65:2170-2178
2. Bertucci F, Finetti P, Rougemont J, Charafe-Jauffret E, Nasser V, Loriod B et al (2004) Gene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapy. Cancer Res 64:8558-8565
3. Bieche I, Lerebours F, Tozlu S, Espie M, Marty M, Lidereau R (2004) Molecular profiling of inflammatory breast cancer: identification of a poor-prognosis gene expression signature. Clin Cancer Res 10:6789-6795
4. Dressman HK, Hans C, Bild A, Olson JA, Rosen E, Marcom PK et al (2006) Gene expression profiles of multiple breast cancer phenotypes and response to neoadjuvant chemotherapy. Clin Cancer Res 12:819-826
5. Iwamoto T, Bianchini G, Qi Y, Cristofanilli M, Lucci A, Woodward WA et al (2011) Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer. Breast Cancer Res Treat 125:785-795
6. Nguyen DM, Sam K, Tsimelzon A, Li X, Wong H, Mohsin S et al (2006) Molecular heterogeneity of inflammatory breast cancer: a hyperproliferative phenotype. Clin Cancer Res 12:5047-5054
7. Van Laere S, Van der Auwera I, Van den Eynden G, Van Hummelen P, van Dam P, Van Marck E et al (2007) Distinct molecular phenotype of inflammatory breast cancer compared to non-inflammatory breast cancer using Affymetrix-based genome-wide gene-expression analysis. Br J Cancer 97:1165-1174
8. Van Laere S, Van der Auwera I, Van den Eynden GG, Fox SB, Bianchi F, Harris AL et al (2005) Distinct molecular signature of inflammatory breast cancer by cDNA microarray analysis. Breast Cancer Res Treat 93:237-246
9. Van Laere SJ, Van den Eynden GG, Van der Auwera I, Vandenberghe M, van Dam P, Van Marck EA et al (2006) Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling. Breast Cancer Res Treat 95:243-255
10. Van Laere SJ, Van der Auwera I, Van den Eynden GG, Elst HJ, Weyler J, Harris AL et al (2006) Nuclear factor-kappaB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kappaB DNA-binding. Clin Cancer Res 12:3249-3256
11. Boersma BJ, Reimers M, Yi M, Ludwig JA, Luke BT, Stephens RM et al (2008) A stromal gene signature associated with inflammatory breast cancer. Int J Cancer 122:1324-1332
12. Dawood S, Merajver SD, Viens P, Vermeulen PB, Swain SM, Buchholz TA et al (2011) International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Ann oncol 22:515-523
13. Sircoulomb F, Bekhouche I, Finetti P, Adelaide J, Ben Hamida A, Bonansea J et al (2010) Genome profiling of ERBB2-amplified breast cancers. BMC Cancer 10:539
14. Van der Auwera I, Bovie C, Svensson C, Limame R, Trinh XB, van Dam P et al (2009) Quantitative assessment of DNA hypermethylation in the inflammatory and non-inflammatory breast cancer phenotypes. Cancer Biol Ther 8:2252-2259